𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Statistical issues in phase III human immunodeficiency virus vaccine trial design

✍ Scribed by M. E. Halloran

Book ID
108547190
Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
277 KB
Volume
161
Category
Article
ISSN
0964-1998

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase 1/2 trial of BMS-275291 in patient
Phase 1/2 trial of BMS-275291 in patients with human immunodeficiency virus-related Kaposi sarcoma : A multicenter trial of the AIDS Malignancy Consortium
✍ Brett T. Brinker; Susan E. Krown; Jeannette Y. Lee; Ethel Cesarman; Amy Chadburn πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 85 KB

## Abstract ## BACKGROUND. Matrix metalloproteinases (MMPs) are overexpressed in Kaposi sarcoma (KS). The safety and efficacy of a novel, orally bioavailable MMP inhibitor, BMS‐275291, was evaluated in patients with human immunodeficiency virus‐associated KS and the correlation between changes in